Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	665.13	661.82	607.52	667.24	579.78	520.4
Revenue Growth (YoY)	5.55%	8.94%	-8.95%	15.09%	11.41%	32.50%
Cost of Revenue	76.27	77.91	83.78	87.22	75.06	52.46
Gross Profit	588.85	583.91	523.74	580.02	504.71	467.94
Selling, General & Admin	332.66	321.58	336.36	377.22	304.76	200.68
Depreciation & Amortization Expenses	78.34	77.98	82.39	82.63	29.99	15.7
Research & Development	106.73	108.8	91.59	74.55	90.47	75.96
Other Operating Expenses	7	-6.11	18.67	-0.51	-6.53	1.9
Total Operating Expenses	524.72	502.25	529.01	533.89	418.69	294.24
Operating Income	64.14	81.67	-5.27	46.12	86.03	173.7
Interest Income	18.03	16.2	10.45	21.69	10.57	18.7
Interest Expense	-	-	-2.42	-7.07	-23.42	-23.75
Total Non-Operating Income (Expense)	18.03	16.2	8.04	14.62	-12.85	-5.05
Pretax Income	82.16	97.87	2.77	60.74	73.18	168.65
Provision for Income Taxes	17.67	24.01	1.45	0.03	19.75	41.7
Net Income	64.5	73.87	1.32	60.71	53.42	126.95
Net Income to Common	64.5	73.87	1.32	60.71	53.42	126.95
Net Income Growth	1131.09%	5512.84%	-97.83%	13.64%	-57.92%	12.29%
Shares Outstanding (Basic)	56	55	55	54	53	53
Shares Outstanding (Diluted)	56	56	56	62	54	54
Shares Change (YoY)	3.96%	0.81%	-10.01%	13.47%	1.24%	-0.24%
EPS (Basic)	1.17	1.34	0.02	1.13	1.01	2.41
EPS (Diluted)	1.15	1.32	0.02	1.04	0.98	2.36
EPS Growth	945.45%	6500.00%	-98.08%	6.12%	-58.48%	12.38%
Free Cash Flow	185.87	171.23	110.53	116.41	125.08	134.71
Free Cash Flow Growth	8.55%	54.91%	-5.05%	-6.93%	-7.15%	-4.96%
Free Cash Flow Per Share	3.30	3.06	1.99	1.89	2.30	2.51
Gross Margin	88.53%	88.23%	86.21%	86.93%	87.05%	89.92%
Operating Margin	9.64%	12.34%	-0.87%	6.91%	14.84%	33.38%
Profit Margin	9.70%	11.16%	0.22%	9.10%	9.21%	24.39%
FCF Margin	27.94%	25.87%	18.19%	17.45%	21.57%	25.89%
EBITDA	144.82	162.08	79.59	131.67	118.62	191.84
EBITDA Margin	21.77%	24.49%	13.10%	19.73%	20.46%	36.86%
EBIT	64.14	81.67	-5.27	46.12	86.03	173.7
EBIT Margin	9.64%	12.34%	-0.87%	6.91%	14.84%	33.38%
Effective Tax Rate	21.50%	24.53%	52.47%	0.05%	26.99%	24.72%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q